BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Prostate cancer AND RHOH, TTF, 399, ENSG00000168421, ARHH, RhoH AND Prognosis
12 results:

  • 1. Collecting duct carcinoma: Epidemiology, clinical characteristics and survival.
    Panunzio A; Tappero S; Hohenhorst L; Cano Garcia C; Piccinelli M; Barletta F; Tian Z; Tafuri A; Briganti A; De Cobelli O; Chun FKH; Tilki D; Terrone C; Kapoor A; Saad F; Shariat SF; Cerruto MA; Antonelli A; Karakiewicz PI
    Urol Oncol; 2023 Feb; 41(2):110.e7-110.e14. PubMed ID: 36456452
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Clinicopathologic features of metastatic small cell carcinoma of the prostate to the liver: a series of four cases.
    Bell PD; Huber AR; Agostini-Vulaj D
    Diagn Pathol; 2021 Apr; 16(1):35. PubMed ID: 33892760
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Multiparametric MRI in the Diagnosis of prostate cancer: Physical Foundations, Limitations, and Prospective Advances of Diffusion-Weighted MRI.
    Wichtmann BD; Zöllner FG; Attenberger UI; Schönberg SO
    Rofo; 2021 Apr; 193(4):399-409. PubMed ID: 33302312
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Gleason scores in prostate needle biopsy and prostatectomy specimens in prostatic adenocarcinoma: A correlation study.
    Awang A; Md Isa N; Yunus R; Azhar Shah S; Md Pauzi SH
    Malays J Pathol; 2019 Dec; 41(3):253-257. PubMed ID: 31901909
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. [Descriptive epidemiology of cancer in metropolitan France: Incidence, survival and prevalence].
    Cowppli-Bony A; Colonna M; Ligier K; Jooste V; Defossez G; Monnereau A; ;
    Bull Cancer; 2019; 106(7-8):617-634. PubMed ID: 30833045
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Oncocytic poorly differentiated (insular) thyroid carcinoma mimicking metastatic adenocarcinoma. A case report and review of the literature.
    Laforga JB; Cortés VA
    Diagn Cytopathol; 2019 Jun; 47(6):584-588. PubMed ID: 30637975
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Identifying cancer origin using circulating tumor cells.
    Lu SH; Tsai WS; Chang YH; Chou TY; Pang ST; Lin PH; Tsai CM; Chang YC
    Cancer Biol Ther; 2016 Apr; 17(4):430-8. PubMed ID: 26828696
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Treg-Mediated Immune Tolerance and the Risk of Solid cancers: Findings From EPIC-Heidelberg.
    Barth SD; Schulze JJ; Kühn T; Raschke E; Hüsing A; Johnson T; Kaaks R; Olek S
    J Natl Cancer Inst; 2015 Nov; 107(11):. PubMed ID: 26298011
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Small cell-like change in prostatic intraepithelial neoplasia, intraductal carcinoma, and invasive prostatic carcinoma: a study of 7 cases.
    Lee S; Han JS; Chang A; Ross HM; Montironi R; Yorukoglu K; Lane Z; Epstein JI
    Hum Pathol; 2013 Mar; 44(3):427-31. PubMed ID: 23026197
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Primary tumor prevalence has an impact on the constituent ratio of metastases to the jaw but not on metastatic sites.
    Zhang FG; Hua CG; Shen ML; Tang XF
    Int J Oral Sci; 2011 Jul; 3(3):141-52. PubMed ID: 21789963
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Extrapulmonary small cell: a novel case of small cell carcinoma of the thyroid gland.
    Beach DF; Klump WJ; Haddad G; Reid LM; Schwarting R; Hageboutros A
    Med Oncol; 2012 Sep; 29(3):1405-8. PubMed ID: 21644012
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Efficacy of primary hormonal therapy for patients with localized and locally advanced prostate cancer: a retrospective multicenter study.
    Ueno S; Namiki M; Fukagai T; Ehara H; Usami M; Akaza H
    Int J Urol; 2006 Dec; 13(12):1494-500. PubMed ID: 17118024
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.